Semaglutide
STEP12
Novo Nordisk · Phase 3 · Completed · Enrollment 242
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide 2.4 milligram (mg) | n/r | n/r | n/r | n/r | n/r |
| Placebo | 2 participants | 0 participants | 6 participants | n/r | 0 |
| Semaglutide 2.4 mg | 29 participants | 16 participants | 30 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.